{"title":"SARS-CoV-2 Viral Isolates","description":"\u003cp\u003eROCR produces viral isolates for characterization and to support the development of antivirals and vaccines. \u003c\/p\u003e","products":[{"product_id":"hcov-19-usa-ny-mshspsp-pv301922-2024-lp-8-1","title":"hCoV-19\/USA\/NY-MSHSPSP-PV301922\/2024 (LP.8.1)","description":"\u003cpre class=\"genbank\"\u003eThe primary isolate was cultured from a clinical nasal swab on \u003cbr\u003eVeroE6-TMPRSS2-ACE2 at Biosafety Level 3. \u003cbr\u003eThis passage 4 viral stock has a titer of 1.18x107 TCID50\/mL \u003cbr\u003eon VeroE6-TMPRSS2 cells. The viral stock has been sequence verified \u003cbr\u003e(complete genome). We have 125µl\/vial aliquots, stored at -80C, available.\u003cbr\u003e\u003cbr\u003ePrice: $1,250.00 per cryovial\u003c\/pre\u003e","brand":"ROCR: Repository of C-VaRPP Reagents","offers":[{"title":"Default Title","offer_id":43696928424024,"sku":"42","price":1250.0,"currency_code":"USD","in_stock":true}]}],"url":"https:\/\/rocr.shop\/collections\/influenza-copy.oembed","provider":"ROCR: Repository of C-VaRPP Reagents","version":"1.0","type":"link"}